Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 105 | 2024 | 1030 | 14.390 |
Why?
|
TOR Serine-Threonine Kinases | 43 | 2024 | 2057 | 4.280 |
Why?
|
Spastic Paraplegia, Hereditary | 16 | 2024 | 168 | 3.570 |
Why?
|
Autistic Disorder | 21 | 2023 | 1216 | 3.320 |
Why?
|
Induced Pluripotent Stem Cells | 15 | 2024 | 1842 | 2.820 |
Why?
|
Tumor Suppressor Proteins | 34 | 2024 | 2800 | 2.550 |
Why?
|
Neurons | 42 | 2024 | 9416 | 2.550 |
Why?
|
Adaptor Protein Complex 4 | 9 | 2023 | 40 | 2.130 |
Why?
|
Epilepsy | 26 | 2024 | 3269 | 1.890 |
Why?
|
Sturge-Weber Syndrome | 8 | 2024 | 85 | 1.800 |
Why?
|
Purkinje Cells | 6 | 2021 | 226 | 1.750 |
Why?
|
Axons | 11 | 2024 | 1673 | 1.680 |
Why?
|
Cilia | 4 | 2021 | 493 | 1.670 |
Why?
|
Survival of Motor Neuron 1 Protein | 6 | 2018 | 64 | 1.630 |
Why?
|
Seizures | 17 | 2024 | 2919 | 1.610 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 4 | 2024 | 96 | 1.450 |
Why?
|
Chromosome Disorders | 10 | 2024 | 499 | 1.450 |
Why?
|
Brain | 66 | 2024 | 26947 | 1.390 |
Why?
|
Cerebellum | 8 | 2018 | 1497 | 1.340 |
Why?
|
GTPase-Activating Proteins | 3 | 2022 | 474 | 1.310 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 4 | 2024 | 282 | 1.290 |
Why?
|
Sirolimus | 12 | 2024 | 1533 | 1.190 |
Why?
|
Rett Syndrome | 4 | 2018 | 164 | 1.120 |
Why?
|
Spasms, Infantile | 6 | 2021 | 296 | 1.110 |
Why?
|
Muscular Atrophy, Spinal | 5 | 2018 | 258 | 1.110 |
Why?
|
Chromosome Deletion | 11 | 2024 | 1387 | 1.110 |
Why?
|
Signal Transduction | 31 | 2024 | 23342 | 1.050 |
Why?
|
ARNTL Transcription Factors | 2 | 2017 | 94 | 1.040 |
Why?
|
Behavior, Animal | 6 | 2020 | 1866 | 1.020 |
Why?
|
Hamartoma Syndrome, Multiple | 6 | 2024 | 114 | 1.010 |
Why?
|
Developmental Disabilities | 10 | 2024 | 1504 | 0.960 |
Why?
|
Autophagy | 7 | 2021 | 1322 | 0.910 |
Why?
|
Pentylenetetrazole | 2 | 2021 | 71 | 0.910 |
Why?
|
Convulsants | 2 | 2021 | 70 | 0.900 |
Why?
|
Fragile X Mental Retardation Protein | 2 | 2021 | 116 | 0.870 |
Why?
|
Animals | 98 | 2024 | 167768 | 0.870 |
Why?
|
PTEN Phosphohydrolase | 12 | 2024 | 1113 | 0.820 |
Why?
|
Disease Models, Animal | 28 | 2024 | 18119 | 0.810 |
Why?
|
rhoA GTP-Binding Protein | 3 | 2021 | 234 | 0.790 |
Why?
|
Vigabatrin | 6 | 2024 | 88 | 0.760 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 17768 | 0.750 |
Why?
|
Child, Preschool | 79 | 2024 | 42062 | 0.740 |
Why?
|
Chromosomes, Human, Pair 16 | 3 | 2021 | 342 | 0.730 |
Why?
|
Synaptic Transmission | 3 | 2024 | 1169 | 0.700 |
Why?
|
Electroencephalography | 23 | 2022 | 6187 | 0.700 |
Why?
|
Humans | 229 | 2024 | 758406 | 0.670 |
Why?
|
Mice | 56 | 2024 | 81101 | 0.660 |
Why?
|
Corpus Callosum | 3 | 2021 | 749 | 0.660 |
Why?
|
Heat-Shock Response | 1 | 2020 | 179 | 0.660 |
Why?
|
Protein Biosynthesis | 5 | 2015 | 2105 | 0.650 |
Why?
|
Nerve Tissue Proteins | 9 | 2024 | 4406 | 0.640 |
Why?
|
Receptor, EphA1 | 3 | 2010 | 20 | 0.630 |
Why?
|
Mutation | 29 | 2024 | 29915 | 0.610 |
Why?
|
Social Isolation | 1 | 2021 | 362 | 0.610 |
Why?
|
Dendritic Spines | 3 | 2015 | 243 | 0.600 |
Why?
|
Central Nervous System Agents | 1 | 2018 | 75 | 0.600 |
Why?
|
Genetic Association Studies | 6 | 2024 | 2717 | 0.590 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 16 | 0.590 |
Why?
|
Magnetic Resonance Imaging | 29 | 2024 | 36284 | 0.560 |
Why?
|
Connective Tissue Growth Factor | 1 | 2017 | 91 | 0.560 |
Why?
|
Nerve Net | 5 | 2021 | 2263 | 0.560 |
Why?
|
Multiprotein Complexes | 10 | 2017 | 1120 | 0.550 |
Why?
|
Myelin Sheath | 2 | 2019 | 652 | 0.540 |
Why?
|
Anticonvulsants | 9 | 2023 | 1881 | 0.540 |
Why?
|
Cells, Cultured | 23 | 2021 | 18940 | 0.540 |
Why?
|
Lysosomal Storage Diseases, Nervous System | 1 | 2015 | 8 | 0.530 |
Why?
|
Phenotype | 22 | 2024 | 16534 | 0.530 |
Why?
|
Fasting | 1 | 2022 | 1599 | 0.530 |
Why?
|
Models, Biological | 7 | 2021 | 9460 | 0.520 |
Why?
|
Diffusion Tensor Imaging | 13 | 2024 | 2386 | 0.520 |
Why?
|
Chromosomes, Human, Pair 22 | 8 | 2024 | 346 | 0.520 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2015 | 45 | 0.520 |
Why?
|
Fetal Macrosomia | 1 | 2016 | 131 | 0.510 |
Why?
|
Infant | 54 | 2024 | 36055 | 0.500 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2014 | 29 | 0.500 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2015 | 55 | 0.500 |
Why?
|
Activating Transcription Factor 3 | 1 | 2015 | 53 | 0.490 |
Why?
|
Mice, Knockout | 18 | 2022 | 14354 | 0.490 |
Why?
|
Adolescent Development | 1 | 2018 | 282 | 0.490 |
Why?
|
Growth Cones | 5 | 2010 | 117 | 0.490 |
Why?
|
Ataxia | 1 | 2017 | 305 | 0.480 |
Why?
|
Cystadenoma | 1 | 2014 | 79 | 0.480 |
Why?
|
Gelsolin | 1 | 2015 | 189 | 0.480 |
Why?
|
Neuroprotective Agents | 3 | 2019 | 955 | 0.480 |
Why?
|
Child | 67 | 2024 | 79818 | 0.480 |
Why?
|
Malformations of Cortical Development | 4 | 2022 | 176 | 0.480 |
Why?
|
Social Behavior | 3 | 2018 | 1131 | 0.470 |
Why?
|
Male | 116 | 2024 | 358747 | 0.470 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.470 |
Why?
|
Motor Neurons | 3 | 2018 | 864 | 0.460 |
Why?
|
Plagiarism | 1 | 2014 | 22 | 0.460 |
Why?
|
Neural Pathways | 6 | 2019 | 3039 | 0.460 |
Why?
|
Cerebral Palsy | 4 | 2022 | 472 | 0.460 |
Why?
|
Receptors, Eph Family | 4 | 2010 | 45 | 0.450 |
Why?
|
Astrocytoma | 3 | 2020 | 775 | 0.440 |
Why?
|
Rhabdomyoma | 3 | 2008 | 54 | 0.440 |
Why?
|
Neural Stem Cells | 2 | 2024 | 882 | 0.440 |
Why?
|
Synapses | 5 | 2018 | 1757 | 0.440 |
Why?
|
Retinitis Pigmentosa | 1 | 2017 | 397 | 0.440 |
Why?
|
Female | 116 | 2024 | 390323 | 0.440 |
Why?
|
Behavior | 3 | 2015 | 540 | 0.440 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 344 | 0.440 |
Why?
|
MicroRNAs | 5 | 2018 | 3783 | 0.440 |
Why?
|
Child Behavior | 2 | 2018 | 847 | 0.430 |
Why?
|
Adolescent | 55 | 2024 | 87892 | 0.430 |
Why?
|
Angiomatosis | 1 | 2013 | 46 | 0.430 |
Why?
|
Circadian Clocks | 1 | 2015 | 163 | 0.420 |
Why?
|
Status Epilepticus | 4 | 2011 | 456 | 0.420 |
Why?
|
Genetic Testing | 6 | 2024 | 3530 | 0.420 |
Why?
|
Hemangiosarcoma | 1 | 2014 | 216 | 0.410 |
Why?
|
Nerve Fibers, Myelinated | 6 | 2015 | 952 | 0.400 |
Why?
|
Alleles | 6 | 2024 | 6895 | 0.400 |
Why?
|
Genes, Duplicate | 1 | 2012 | 30 | 0.400 |
Why?
|
Child Development | 3 | 2019 | 2285 | 0.400 |
Why?
|
Pluripotent Stem Cells | 4 | 2023 | 792 | 0.400 |
Why?
|
Rats | 21 | 2023 | 23679 | 0.390 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2012 | 635 | 0.390 |
Why?
|
Child Development Disorders, Pervasive | 6 | 2014 | 600 | 0.390 |
Why?
|
Germ-Line Mutation | 5 | 2024 | 1840 | 0.380 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2022 | 2872 | 0.380 |
Why?
|
Protein Kinases | 3 | 2014 | 1610 | 0.370 |
Why?
|
Mental Disorders | 6 | 2022 | 6803 | 0.370 |
Why?
|
Evoked Potentials | 1 | 2017 | 1036 | 0.370 |
Why?
|
Migraine Disorders | 1 | 2023 | 1694 | 0.370 |
Why?
|
Ephrin-A1 | 2 | 2010 | 9 | 0.370 |
Why?
|
Genetic Counseling | 1 | 2015 | 624 | 0.370 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 2009 | 435 | 0.360 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 597 | 0.360 |
Why?
|
Epilepsies, Partial | 4 | 2021 | 430 | 0.350 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 520 | 0.350 |
Why?
|
Heart Neoplasms | 3 | 2008 | 360 | 0.350 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1184 | 0.340 |
Why?
|
Neuronal Plasticity | 2 | 2016 | 1429 | 0.340 |
Why?
|
Mice, Inbred CBA | 3 | 2021 | 436 | 0.330 |
Why?
|
Organoids | 3 | 2024 | 729 | 0.320 |
Why?
|
Editorial Policies | 1 | 2014 | 456 | 0.320 |
Why?
|
Neurogenesis | 4 | 2020 | 855 | 0.320 |
Why?
|
Stem Cells | 2 | 2020 | 3521 | 0.320 |
Why?
|
Genotype | 10 | 2024 | 12945 | 0.320 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2021 | 143 | 0.310 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2010 | 200 | 0.310 |
Why?
|
Metformin | 1 | 2016 | 907 | 0.310 |
Why?
|
Protein Tyrosine Phosphatases | 3 | 1995 | 459 | 0.310 |
Why?
|
Maze Learning | 3 | 2017 | 477 | 0.310 |
Why?
|
Proteins | 8 | 2024 | 6026 | 0.310 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8945 | 0.300 |
Why?
|
Cognition Disorders | 4 | 2018 | 3975 | 0.300 |
Why?
|
Birth Weight | 1 | 2016 | 2097 | 0.300 |
Why?
|
Thyroid Neoplasms | 1 | 2021 | 2332 | 0.290 |
Why?
|
Neuropeptides | 2 | 2011 | 943 | 0.290 |
Why?
|
Spasm | 1 | 2008 | 130 | 0.290 |
Why?
|
Cerebral Cortex | 8 | 2024 | 5759 | 0.290 |
Why?
|
Memory | 1 | 2017 | 2179 | 0.290 |
Why?
|
Guanine Nucleotide Exchange Factors | 4 | 2006 | 568 | 0.290 |
Why?
|
Hippocampus | 6 | 2020 | 3736 | 0.280 |
Why?
|
Anxiety | 4 | 2023 | 4539 | 0.280 |
Why?
|
Heterozygote | 6 | 2021 | 2797 | 0.270 |
Why?
|
Nervous System Diseases | 2 | 2014 | 1647 | 0.270 |
Why?
|
Gene Expression | 6 | 2021 | 7583 | 0.270 |
Why?
|
Anisotropy | 10 | 2024 | 1278 | 0.270 |
Why?
|
Immunosuppressive Agents | 3 | 2018 | 4158 | 0.270 |
Why?
|
Protein Transport | 2 | 2024 | 1963 | 0.260 |
Why?
|
DNA Copy Number Variations | 4 | 2022 | 2012 | 0.260 |
Why?
|
Weight Gain | 1 | 2016 | 2346 | 0.260 |
Why?
|
Central Nervous System | 2 | 2011 | 1333 | 0.260 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2018 | 2782 | 0.260 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2567 | 0.260 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2014 | 1887 | 0.260 |
Why?
|
Fragile X Syndrome | 2 | 2018 | 116 | 0.250 |
Why?
|
Grooming | 2 | 2017 | 38 | 0.250 |
Why?
|
Triiodobenzoic Acids | 1 | 2005 | 123 | 0.240 |
Why?
|
Thyroiditis, Subacute | 1 | 2024 | 11 | 0.240 |
Why?
|
Pregnancy Complications | 2 | 2016 | 2942 | 0.240 |
Why?
|
Checklist | 3 | 2023 | 827 | 0.230 |
Why?
|
Neocortex | 2 | 2020 | 416 | 0.230 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2020 | 112 | 0.230 |
Why?
|
Embryo, Mammalian | 8 | 2011 | 1674 | 0.230 |
Why?
|
Genetic Variation | 4 | 2024 | 6548 | 0.230 |
Why?
|
Quality of Life | 2 | 2023 | 13285 | 0.230 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 22003 | 0.230 |
Why?
|
Cell Line | 9 | 2024 | 15591 | 0.220 |
Why?
|
Cell Differentiation | 7 | 2024 | 11471 | 0.220 |
Why?
|
Cell Movement | 2 | 2020 | 5201 | 0.220 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3069 | 0.220 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7378 | 0.220 |
Why?
|
Granulosa Cell Tumor | 1 | 2024 | 72 | 0.220 |
Why?
|
Young Adult | 27 | 2024 | 58808 | 0.220 |
Why?
|
Endometrial Hyperplasia | 1 | 2024 | 97 | 0.210 |
Why?
|
Lysosomes | 3 | 2021 | 919 | 0.210 |
Why?
|
Longitudinal Studies | 16 | 2024 | 14490 | 0.210 |
Why?
|
Lissencephaly | 2 | 2020 | 36 | 0.200 |
Why?
|
Models, Genetic | 2 | 2012 | 3441 | 0.200 |
Why?
|
Vocalization, Animal | 2 | 2012 | 93 | 0.200 |
Why?
|
Encephalitis | 3 | 2011 | 438 | 0.200 |
Why?
|
Dependovirus | 2 | 2024 | 711 | 0.200 |
Why?
|
Brain Diseases | 3 | 2018 | 1541 | 0.200 |
Why?
|
Neuropsychiatry | 2 | 2019 | 76 | 0.200 |
Why?
|
Mice, Transgenic | 10 | 2018 | 9518 | 0.200 |
Why?
|
Tyrosine | 2 | 2006 | 1432 | 0.190 |
Why?
|
Action Potentials | 2 | 2019 | 1816 | 0.190 |
Why?
|
RNA, Messenger | 4 | 2014 | 12759 | 0.190 |
Why?
|
Language Development | 2 | 2019 | 181 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2020 | 2443 | 0.190 |
Why?
|
Rats, Long-Evans | 3 | 2017 | 378 | 0.190 |
Why?
|
Evoked Potentials, Visual | 2 | 2015 | 415 | 0.190 |
Why?
|
Papilloma | 1 | 2022 | 141 | 0.190 |
Why?
|
Endocannabinoids | 1 | 2022 | 111 | 0.190 |
Why?
|
Rare Diseases | 3 | 2022 | 619 | 0.180 |
Why?
|
Up-Regulation | 3 | 2021 | 4113 | 0.180 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2024 | 1132 | 0.180 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 172 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2858 | 0.180 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2015 | 3339 | 0.180 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5786 | 0.180 |
Why?
|
Blood-Brain Barrier | 2 | 2024 | 1018 | 0.180 |
Why?
|
Mice, 129 Strain | 1 | 2021 | 372 | 0.180 |
Why?
|
Carrier Proteins | 4 | 2011 | 4938 | 0.180 |
Why?
|
Seizures, Febrile | 2 | 2011 | 108 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3418 | 0.180 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2020 | 66 | 0.180 |
Why?
|
Carbamazepine | 2 | 2017 | 224 | 0.180 |
Why?
|
Organic Chemicals | 1 | 2021 | 211 | 0.180 |
Why?
|
trans-Golgi Network | 1 | 2020 | 33 | 0.180 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2496 | 0.170 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3204 | 0.170 |
Why?
|
Pruritus | 1 | 2023 | 377 | 0.170 |
Why?
|
RNA, Small Interfering | 4 | 2015 | 3432 | 0.170 |
Why?
|
Reproducibility of Results | 13 | 2023 | 20055 | 0.170 |
Why?
|
Benzoquinones | 1 | 2020 | 198 | 0.170 |
Why?
|
Gene Expression Regulation | 6 | 2019 | 11892 | 0.170 |
Why?
|
Software | 1 | 2014 | 4415 | 0.170 |
Why?
|
Oxidative Stress | 3 | 2010 | 3099 | 0.170 |
Why?
|
Blotting, Western | 6 | 2015 | 5031 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.170 |
Why?
|
Penetrance | 1 | 2021 | 388 | 0.170 |
Why?
|
Brain Neoplasms | 4 | 2020 | 8981 | 0.170 |
Why?
|
Glycogen Storage Disease Type II | 1 | 1999 | 43 | 0.170 |
Why?
|
Cognition | 5 | 2021 | 6953 | 0.160 |
Why?
|
Excitatory Postsynaptic Potentials | 3 | 2016 | 368 | 0.160 |
Why?
|
Genes, Lethal | 1 | 2019 | 225 | 0.160 |
Why?
|
Computational Biology | 1 | 2011 | 3502 | 0.160 |
Why?
|
Kidney Neoplasms | 2 | 2017 | 4312 | 0.160 |
Why?
|
Reactive Oxygen Species | 3 | 2013 | 2129 | 0.160 |
Why?
|
Scalp | 2 | 2019 | 389 | 0.160 |
Why?
|
Endothelial Cells | 4 | 2022 | 3533 | 0.160 |
Why?
|
Hamartoma | 1 | 2021 | 235 | 0.160 |
Why?
|
Adult | 29 | 2024 | 219935 | 0.160 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 315 | 0.160 |
Why?
|
Survival of Motor Neuron 2 Protein | 1 | 2018 | 49 | 0.160 |
Why?
|
Capillaries | 1 | 2021 | 744 | 0.150 |
Why?
|
Pedigree | 5 | 2022 | 4578 | 0.150 |
Why?
|
Phospholipase C beta | 2 | 2021 | 49 | 0.150 |
Why?
|
Visual Perception | 2 | 2018 | 1374 | 0.150 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2017 | 23 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
Gliosis | 3 | 2019 | 244 | 0.150 |
Why?
|
Ribosomes | 1 | 2021 | 501 | 0.150 |
Why?
|
Microarray Analysis | 2 | 2022 | 746 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2470 | 0.150 |
Why?
|
Neonatal Screening | 1 | 2022 | 594 | 0.150 |
Why?
|
Language | 3 | 2023 | 1532 | 0.150 |
Why?
|
Microcephaly | 1 | 2021 | 425 | 0.150 |
Why?
|
Thalamus | 2 | 1995 | 1040 | 0.150 |
Why?
|
Iodine Radioisotopes | 1 | 2021 | 1032 | 0.140 |
Why?
|
World Health Organization | 1 | 2023 | 1312 | 0.140 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 423 | 0.140 |
Why?
|
Models, Neurological | 3 | 2015 | 1757 | 0.140 |
Why?
|
Stereotypic Movement Disorder | 1 | 2017 | 30 | 0.140 |
Why?
|
Gene Frequency | 1 | 2024 | 3612 | 0.140 |
Why?
|
Phosphorylation | 8 | 2015 | 8297 | 0.140 |
Why?
|
Infant, Newborn | 13 | 2022 | 26183 | 0.140 |
Why?
|
Vesicular Transport Proteins | 1 | 2020 | 374 | 0.140 |
Why?
|
Age Factors | 6 | 2021 | 18358 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2417 | 0.140 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6209 | 0.140 |
Why?
|
Barbiturates | 1 | 2017 | 113 | 0.140 |
Why?
|
Databases, Genetic | 1 | 2023 | 1737 | 0.140 |
Why?
|
Receptor, EphA4 | 2 | 2006 | 17 | 0.140 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 614 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2021 | 799 | 0.130 |
Why?
|
Mosaicism | 2 | 2019 | 465 | 0.130 |
Why?
|
Allosteric Regulation | 1 | 2017 | 426 | 0.130 |
Why?
|
Amino Acids | 1 | 2022 | 1713 | 0.130 |
Why?
|
Segmental Duplications, Genomic | 1 | 2016 | 19 | 0.130 |
Why?
|
Vascular Malformations | 1 | 2022 | 464 | 0.130 |
Why?
|
Ribonuclease III | 1 | 2018 | 279 | 0.130 |
Why?
|
Cell Respiration | 1 | 2016 | 202 | 0.130 |
Why?
|
Angiofibroma | 1 | 2016 | 55 | 0.130 |
Why?
|
Microscopy, Atomic Force | 1 | 2016 | 247 | 0.130 |
Why?
|
Cerebellar Diseases | 1 | 2018 | 219 | 0.130 |
Why?
|
Diencephalon | 1 | 1995 | 54 | 0.130 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2017 | 187 | 0.130 |
Why?
|
Apnea | 1 | 2017 | 195 | 0.130 |
Why?
|
Brain Waves | 1 | 2020 | 401 | 0.130 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2013 | 1171 | 0.130 |
Why?
|
GABA Agents | 1 | 2015 | 41 | 0.130 |
Why?
|
Microscopy | 1 | 2020 | 884 | 0.130 |
Why?
|
Basal Ganglia | 1 | 2018 | 552 | 0.130 |
Why?
|
Coma | 2 | 2017 | 482 | 0.130 |
Why?
|
Albinism | 1 | 2015 | 24 | 0.130 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 293 | 0.130 |
Why?
|
Facial Neoplasms | 1 | 2016 | 125 | 0.130 |
Why?
|
Frameshift Mutation | 1 | 2017 | 388 | 0.120 |
Why?
|
Prospective Studies | 16 | 2024 | 54137 | 0.120 |
Why?
|
Huntington Disease | 1 | 2022 | 1141 | 0.120 |
Why?
|
Retrospective Studies | 17 | 2024 | 80168 | 0.120 |
Why?
|
Immunoprecipitation | 1 | 2017 | 877 | 0.120 |
Why?
|
Age of Onset | 3 | 2021 | 3298 | 0.120 |
Why?
|
rho GTP-Binding Proteins | 3 | 2005 | 277 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 699 | 0.120 |
Why?
|
Animals, Newborn | 6 | 2010 | 2672 | 0.120 |
Why?
|
3' Untranslated Regions | 2 | 2014 | 514 | 0.120 |
Why?
|
Cell Size | 3 | 2012 | 623 | 0.120 |
Why?
|
Down-Regulation | 2 | 2020 | 2904 | 0.120 |
Why?
|
Receptor, EphA7 | 1 | 2014 | 7 | 0.120 |
Why?
|
Gene Knockdown Techniques | 3 | 2014 | 1610 | 0.120 |
Why?
|
Imidazoles | 2 | 2017 | 1179 | 0.120 |
Why?
|
Pattern Recognition, Automated | 2 | 2012 | 994 | 0.120 |
Why?
|
p120 GTPase Activating Protein | 1 | 2014 | 36 | 0.120 |
Why?
|
Presynaptic Terminals | 1 | 2016 | 301 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2024 | 1357 | 0.120 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 412 | 0.120 |
Why?
|
Receptor, EphB4 | 1 | 2014 | 39 | 0.120 |
Why?
|
Cytoskeletal Proteins | 1 | 2020 | 1342 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2017 | 2564 | 0.110 |
Why?
|
Exodeoxyribonucleases | 1 | 2015 | 192 | 0.110 |
Why?
|
Neurites | 1 | 2016 | 390 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4567 | 0.110 |
Why?
|
Obesity | 1 | 2016 | 12870 | 0.110 |
Why?
|
Association Learning | 1 | 2015 | 220 | 0.110 |
Why?
|
Cohort Studies | 9 | 2024 | 41256 | 0.110 |
Why?
|
Aging | 3 | 2020 | 8650 | 0.110 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2015 | 203 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1023 | 0.110 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 38 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 4048 | 0.110 |
Why?
|
Electroretinography | 1 | 2015 | 517 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 5 | 2015 | 8143 | 0.110 |
Why?
|
Hypothalamus | 1 | 2018 | 998 | 0.110 |
Why?
|
Riluzole | 1 | 2013 | 58 | 0.110 |
Why?
|
Retina | 2 | 2017 | 2635 | 0.110 |
Why?
|
Atrophy | 2 | 2013 | 1627 | 0.110 |
Why?
|
Mitochondria | 3 | 2020 | 3584 | 0.110 |
Why?
|
Oligodendroglia | 1 | 2017 | 536 | 0.110 |
Why?
|
Peroxisomes | 1 | 2013 | 68 | 0.110 |
Why?
|
Rotarod Performance Test | 1 | 2012 | 63 | 0.110 |
Why?
|
Introns | 1 | 2015 | 978 | 0.100 |
Why?
|
Hydrocephalus | 1 | 1999 | 764 | 0.100 |
Why?
|
Ubiquitination | 1 | 2017 | 1006 | 0.100 |
Why?
|
Oligonucleotides, Antisense | 1 | 2015 | 459 | 0.100 |
Why?
|
Astrocytes | 3 | 2024 | 1337 | 0.100 |
Why?
|
Temporal Lobe | 1 | 2020 | 1688 | 0.100 |
Why?
|
Time Factors | 6 | 2020 | 39872 | 0.100 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1751 | 0.100 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 25956 | 0.100 |
Why?
|
Cytosol | 1 | 2015 | 886 | 0.100 |
Why?
|
Retinal Pigment Epithelium | 1 | 2015 | 301 | 0.100 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1133 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3774 | 0.100 |
Why?
|
Stem Cell Factor | 1 | 2012 | 195 | 0.100 |
Why?
|
Receptors, Opioid | 1 | 1992 | 145 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1594 | 0.100 |
Why?
|
Hand | 1 | 2017 | 903 | 0.100 |
Why?
|
Receptors, Muscarinic | 1 | 1992 | 157 | 0.100 |
Why?
|
Animals, Genetically Modified | 2 | 2020 | 1553 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2012 | 802 | 0.100 |
Why?
|
Treatment Outcome | 12 | 2024 | 64378 | 0.100 |
Why?
|
Contrast Media | 1 | 2005 | 5298 | 0.100 |
Why?
|
Genes | 1 | 2015 | 1845 | 0.100 |
Why?
|
Sequence Deletion | 1 | 2016 | 1492 | 0.100 |
Why?
|
Transfection | 3 | 2015 | 5779 | 0.090 |
Why?
|
Cell Shape | 1 | 2012 | 371 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11070 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2016 | 7985 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2638 | 0.090 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2015 | 633 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 786 | 0.090 |
Why?
|
N-Methylaspartate | 1 | 2011 | 231 | 0.090 |
Why?
|
Immunity, Active | 1 | 2010 | 58 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 675 | 0.090 |
Why?
|
Reflex | 1 | 2012 | 376 | 0.090 |
Why?
|
Neuropsychological Tests | 6 | 2023 | 7021 | 0.090 |
Why?
|
Goals | 1 | 2016 | 707 | 0.090 |
Why?
|
Apoptosis | 5 | 2012 | 9468 | 0.090 |
Why?
|
Trisomy | 1 | 2012 | 260 | 0.090 |
Why?
|
Amygdala | 1 | 2018 | 1350 | 0.090 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2012 | 296 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 772 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3816 | 0.090 |
Why?
|
Prenatal Diagnosis | 2 | 2008 | 1264 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2016 | 933 | 0.090 |
Why?
|
Cerebellar Cortex | 1 | 1990 | 107 | 0.090 |
Why?
|
HEK293 Cells | 3 | 2014 | 4257 | 0.090 |
Why?
|
Family Health | 1 | 2015 | 1257 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1433 | 0.080 |
Why?
|
Cataract | 1 | 2015 | 827 | 0.080 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2010 | 141 | 0.080 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 468 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1228 | 0.080 |
Why?
|
Pregnancy | 5 | 2022 | 29742 | 0.080 |
Why?
|
Image Enhancement | 3 | 2015 | 2880 | 0.080 |
Why?
|
Transcription Factor CHOP | 1 | 2009 | 67 | 0.080 |
Why?
|
Tunicamycin | 1 | 2009 | 108 | 0.080 |
Why?
|
Glucose Transporter Type 1 | 1 | 2009 | 186 | 0.080 |
Why?
|
Echinococcus granulosus | 1 | 2008 | 11 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2013 | 681 | 0.080 |
Why?
|
Arthrogryposis | 1 | 2009 | 68 | 0.080 |
Why?
|
Ephrins | 2 | 2005 | 28 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2551 | 0.080 |
Why?
|
Lentivirus | 1 | 2012 | 503 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 1992 | 494 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 510 | 0.080 |
Why?
|
Echinococcosis, Hepatic | 1 | 2008 | 24 | 0.080 |
Why?
|
Chimerin 1 | 1 | 2008 | 13 | 0.080 |
Why?
|
Haploinsufficiency | 1 | 2010 | 327 | 0.080 |
Why?
|
Pyridines | 2 | 2017 | 2859 | 0.080 |
Why?
|
Threonine | 1 | 2009 | 270 | 0.080 |
Why?
|
Brain Mapping | 4 | 2021 | 6570 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 473 | 0.080 |
Why?
|
Pain | 1 | 2023 | 5065 | 0.080 |
Why?
|
Cell Count | 1 | 2012 | 1835 | 0.080 |
Why?
|
In Situ Hybridization | 4 | 2001 | 1900 | 0.080 |
Why?
|
Cytoplasmic Granules | 1 | 2011 | 573 | 0.080 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 129 | 0.080 |
Why?
|
Sesquiterpenes | 1 | 2009 | 176 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 477 | 0.080 |
Why?
|
Zebrafish | 3 | 2020 | 2993 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10748 | 0.070 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1006 | 0.070 |
Why?
|
Video Recording | 3 | 2018 | 954 | 0.070 |
Why?
|
Duane Retraction Syndrome | 1 | 2008 | 59 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2018 | 2209 | 0.070 |
Why?
|
Hypopigmentation | 1 | 2008 | 43 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3615 | 0.070 |
Why?
|
Motor Activity | 1 | 2017 | 2685 | 0.070 |
Why?
|
Middle Aged | 9 | 2024 | 219568 | 0.070 |
Why?
|
Syndrome | 3 | 2009 | 3262 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10504 | 0.070 |
Why?
|
Chick Embryo | 2 | 2008 | 981 | 0.070 |
Why?
|
Sleep | 2 | 2020 | 4744 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5788 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4876 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3193 | 0.070 |
Why?
|
Models, Statistical | 3 | 2018 | 5070 | 0.070 |
Why?
|
Pattern Recognition, Visual | 1 | 2012 | 810 | 0.070 |
Why?
|
Retinal Ganglion Cells | 2 | 2010 | 806 | 0.070 |
Why?
|
Lactones | 1 | 2009 | 317 | 0.070 |
Why?
|
Heme Oxygenase-1 | 1 | 2009 | 363 | 0.070 |
Why?
|
Pregnancy, High-Risk | 1 | 2007 | 119 | 0.070 |
Why?
|
Face | 1 | 2012 | 1017 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14641 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1870 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4023 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2009 | 896 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2005 | 2753 | 0.070 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1130 | 0.070 |
Why?
|
Abnormalities, Multiple | 2 | 2011 | 1414 | 0.070 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2010 | 597 | 0.060 |
Why?
|
Receptor Aggregation | 1 | 2005 | 72 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4106 | 0.060 |
Why?
|
Visual Pathways | 1 | 2010 | 534 | 0.060 |
Why?
|
Maternal Exposure | 1 | 2012 | 1045 | 0.060 |
Why?
|
Transcription Factors | 5 | 2021 | 12094 | 0.060 |
Why?
|
Serine | 1 | 2009 | 828 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15785 | 0.060 |
Why?
|
Cytoplasm | 1 | 2010 | 1514 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8530 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2020 | 7843 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 1332 | 0.060 |
Why?
|
Caenorhabditis elegans | 2 | 2013 | 1444 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 7590 | 0.060 |
Why?
|
Organ Size | 3 | 2018 | 2252 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 408 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2007 | 351 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2666 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12604 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8175 | 0.060 |
Why?
|
Bicuculline | 2 | 2016 | 96 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2006 | 244 | 0.060 |
Why?
|
Caregivers | 1 | 2016 | 2225 | 0.060 |
Why?
|
Amino Acid Sequence | 5 | 2008 | 13447 | 0.060 |
Why?
|
Genetic Vectors | 2 | 2024 | 3380 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3480 | 0.060 |
Why?
|
Consensus | 2 | 2023 | 3099 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2016 | 5864 | 0.060 |
Why?
|
Parents | 3 | 2022 | 3548 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2011 | 1398 | 0.050 |
Why?
|
Melanoma | 1 | 2022 | 5691 | 0.050 |
Why?
|
Genes, Dominant | 2 | 2021 | 862 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2008 | 790 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1995 | 1543 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 172 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3563 | 0.050 |
Why?
|
United States | 6 | 2024 | 72136 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
Poloxamer | 1 | 2022 | 56 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2021 | 9574 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3733 | 0.050 |
Why?
|
Algorithms | 5 | 2018 | 13961 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
Paraplegia | 1 | 2023 | 162 | 0.050 |
Why?
|
Comorbidity | 3 | 2023 | 10495 | 0.050 |
Why?
|
Infant, Newborn, Diseases | 1 | 2008 | 592 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5797 | 0.050 |
Why?
|
Retinoids | 1 | 2022 | 98 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15651 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3754 | 0.050 |
Why?
|
Psychometrics | 2 | 2023 | 3052 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2007 | 1829 | 0.050 |
Why?
|
Monoacylglycerol Lipases | 1 | 2022 | 36 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 73809 | 0.050 |
Why?
|
Pilot Projects | 3 | 2022 | 8553 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6954 | 0.050 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.050 |
Why?
|
Mutant Proteins | 1 | 2023 | 491 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2022 | 156 | 0.050 |
Why?
|
Calpain | 1 | 2022 | 145 | 0.050 |
Why?
|
Axonal Transport | 1 | 2022 | 178 | 0.050 |
Why?
|
Pentobarbital | 1 | 2001 | 152 | 0.050 |
Why?
|
Stereotyped Behavior | 1 | 2021 | 135 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2001 | 6293 | 0.050 |
Why?
|
Sphingolipids | 1 | 2022 | 173 | 0.050 |
Why?
|
Cerebellar Nuclei | 1 | 2021 | 51 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39059 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2001 | 97 | 0.050 |
Why?
|
Cell Survival | 4 | 2012 | 5781 | 0.050 |
Why?
|
Endocytosis | 1 | 2005 | 958 | 0.050 |
Why?
|
Brain Edema | 1 | 2005 | 603 | 0.040 |
Why?
|
Adaptor Protein Complex beta Subunits | 1 | 2020 | 13 | 0.040 |
Why?
|
Muscle Hypotonia | 1 | 2021 | 160 | 0.040 |
Why?
|
Anesthesia | 1 | 2011 | 1582 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2021 | 500 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2912 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2005 | 1167 | 0.040 |
Why?
|
Actins | 2 | 2005 | 2049 | 0.040 |
Why?
|
Midazolam | 1 | 2001 | 266 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4429 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6068 | 0.040 |
Why?
|
Centrioles | 1 | 2020 | 79 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2021 | 250 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15225 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12075 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 463 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1368 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5404 | 0.040 |
Why?
|
Fibroblasts | 3 | 2020 | 4087 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2001 | 396 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 428 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3442 | 0.040 |
Why?
|
Intelligence | 1 | 2023 | 921 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 1999 | 186 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3602 | 0.040 |
Why?
|
Biological Assay | 1 | 2021 | 626 | 0.040 |
Why?
|
Hallucinations | 1 | 2000 | 366 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 769 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22029 | 0.040 |
Why?
|
Hemodiafiltration | 1 | 2017 | 18 | 0.040 |
Why?
|
Photic Stimulation | 2 | 2015 | 1967 | 0.040 |
Why?
|
Telemetry | 1 | 2018 | 199 | 0.040 |
Why?
|
Health Priorities | 1 | 2020 | 375 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2018 | 532 | 0.040 |
Why?
|
Drug Resistance | 1 | 2003 | 1593 | 0.040 |
Why?
|
Learning | 2 | 2019 | 1739 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13591 | 0.040 |
Why?
|
Prognosis | 4 | 2018 | 29557 | 0.040 |
Why?
|
Los Angeles | 1 | 2017 | 243 | 0.040 |
Why?
|
Facies | 1 | 2017 | 222 | 0.040 |
Why?
|
Decontamination | 1 | 2017 | 72 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2024 | 1664 | 0.030 |
Why?
|
Germ Cells | 1 | 2021 | 635 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2021 | 1199 | 0.030 |
Why?
|
DNA Primers | 2 | 2008 | 2816 | 0.030 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 2016 | 58 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 867 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2017 | 206 | 0.030 |
Why?
|
Immune System | 1 | 2022 | 796 | 0.030 |
Why?
|
Headache | 1 | 2024 | 1248 | 0.030 |
Why?
|
Long-Term Synaptic Depression | 1 | 2016 | 60 | 0.030 |
Why?
|
Zinc Fingers | 1 | 1998 | 568 | 0.030 |
Why?
|
Neuroglia | 1 | 2022 | 944 | 0.030 |
Why?
|
Cycloheximide | 1 | 2016 | 343 | 0.030 |
Why?
|
Ligands | 2 | 2014 | 3258 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 3 | 1 | 1995 | 4 | 0.030 |
Why?
|
Dendrites | 2 | 2009 | 474 | 0.030 |
Why?
|
Wavelet Analysis | 1 | 2015 | 55 | 0.030 |
Why?
|
Conditioning, Eyelid | 1 | 2015 | 9 | 0.030 |
Why?
|
Microscopy, Confocal | 2 | 2016 | 1969 | 0.030 |
Why?
|
Information Theory | 1 | 2015 | 49 | 0.030 |
Why?
|
Computer Simulation | 3 | 2015 | 6201 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2016 | 210 | 0.030 |
Why?
|
Affect | 1 | 2023 | 1480 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12096 | 0.030 |
Why?
|
Propofol | 1 | 2001 | 606 | 0.030 |
Why?
|
Gestational Age | 2 | 1995 | 3565 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2016 | 298 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3602 | 0.030 |
Why?
|
Thalamic Nuclei | 1 | 1995 | 111 | 0.030 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2014 | 13 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2001 | 1436 | 0.030 |
Why?
|
Growth Substances | 1 | 2017 | 768 | 0.030 |
Why?
|
Motion | 1 | 2018 | 779 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2144 | 0.030 |
Why?
|
Testis | 1 | 1998 | 794 | 0.030 |
Why?
|
Skin Diseases | 1 | 2023 | 1088 | 0.030 |
Why?
|
Aged | 6 | 2024 | 168218 | 0.030 |
Why?
|
Glutathione | 1 | 2017 | 579 | 0.030 |
Why?
|
Ephrin-A5 | 1 | 2014 | 17 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1074 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2016 | 362 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1998 | 1991 | 0.030 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2014 | 53 | 0.030 |
Why?
|
Skin | 2 | 2023 | 4464 | 0.030 |
Why?
|
Antisense Elements (Genetics) | 1 | 1993 | 37 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1072 | 0.030 |
Why?
|
Dark Adaptation | 1 | 2015 | 221 | 0.030 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2014 | 87 | 0.030 |
Why?
|
RNA Probes | 1 | 1993 | 111 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2008 | 17617 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1659 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 557 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1613 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 787 | 0.030 |
Why?
|
Insulin | 1 | 2008 | 6578 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2005 | 4451 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2015 | 534 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1629 | 0.030 |
Why?
|
Statistical Distributions | 1 | 2013 | 63 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2008 | 20500 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 420 | 0.030 |
Why?
|
Histology | 1 | 2012 | 16 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4839 | 0.030 |
Why?
|
Base Sequence | 3 | 2008 | 12436 | 0.030 |
Why?
|
RNA Interference | 2 | 2012 | 2836 | 0.030 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1992 | 19 | 0.030 |
Why?
|
Acute Disease | 1 | 2003 | 7225 | 0.030 |
Why?
|
Synapsins | 1 | 2012 | 43 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5199 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12951 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3891 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1177 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 2 | 2005 | 458 | 0.030 |
Why?
|
Enkephalins | 1 | 1992 | 139 | 0.020 |
Why?
|
Survival | 1 | 2012 | 160 | 0.020 |
Why?
|
Self Report | 1 | 2023 | 3714 | 0.020 |
Why?
|
Wakefulness | 1 | 2018 | 1256 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2716 | 0.020 |
Why?
|
Pyramidal Cells | 1 | 2014 | 368 | 0.020 |
Why?
|
Biopsy | 1 | 2003 | 6768 | 0.020 |
Why?
|
Language Disorders | 1 | 2012 | 138 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2014 | 535 | 0.020 |
Why?
|
Autoradiography | 1 | 1992 | 730 | 0.020 |
Why?
|
Iron | 1 | 2020 | 1786 | 0.020 |
Why?
|
Sodium Compounds | 1 | 2011 | 35 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2016 | 1732 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9404 | 0.020 |
Why?
|
Motor Skills | 1 | 2014 | 519 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 1992 | 166 | 0.020 |
Why?
|
Vision, Ocular | 1 | 2014 | 454 | 0.020 |
Why?
|
Arsenites | 1 | 2011 | 65 | 0.020 |
Why?
|
Sample Size | 1 | 2014 | 838 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2090 | 0.020 |
Why?
|
Horseradish Peroxidase | 1 | 1990 | 166 | 0.020 |
Why?
|
CA1 Region, Hippocampal | 1 | 2011 | 109 | 0.020 |
Why?
|
Gene Library | 1 | 1993 | 1059 | 0.020 |
Why?
|
PC12 Cells | 1 | 2011 | 317 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 1955 | 0.020 |
Why?
|
Poly I-C | 1 | 2010 | 112 | 0.020 |
Why?
|
Benzamides | 1 | 2016 | 1368 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13468 | 0.020 |
Why?
|
Cytoprotection | 1 | 2011 | 199 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2011 | 180 | 0.020 |
Why?
|
HeLa Cells | 2 | 2006 | 3096 | 0.020 |
Why?
|
Adenylate Kinase | 1 | 2010 | 102 | 0.020 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2009 | 32 | 0.020 |
Why?
|
Artifacts | 1 | 2018 | 1897 | 0.020 |
Why?
|
Dentate Gyrus | 1 | 2010 | 163 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5862 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1927 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2010 | 273 | 0.020 |
Why?
|
Cats | 1 | 1990 | 976 | 0.020 |
Why?
|
Lithium Chloride | 1 | 2009 | 82 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 1990 | 404 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 598 | 0.020 |
Why?
|
Nerve Crush | 1 | 2008 | 76 | 0.020 |
Why?
|
Axotomy | 1 | 2008 | 71 | 0.020 |
Why?
|
Isoenzymes | 1 | 1993 | 1686 | 0.020 |
Why?
|
Light | 1 | 2015 | 1345 | 0.020 |
Why?
|
Abducens Nerve | 1 | 2008 | 28 | 0.020 |
Why?
|
Ribosomal Protein S6 | 1 | 2008 | 71 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3432 | 0.020 |
Why?
|
Granulocytes | 1 | 1990 | 550 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 892 | 0.020 |
Why?
|
Angelman Syndrome | 1 | 2010 | 140 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9267 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4416 | 0.020 |
Why?
|
Blood Vessels | 1 | 2014 | 1112 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12262 | 0.020 |
Why?
|
Oculomotor Nerve | 1 | 2008 | 72 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 609 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2557 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9650 | 0.020 |
Why?
|
Phenylbutyrates | 1 | 2008 | 72 | 0.020 |
Why?
|
DNA | 1 | 2021 | 7199 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1786 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2009 | 550 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1788 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6520 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23884 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2008 | 144 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2011 | 728 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2895 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1533 | 0.020 |
Why?
|
Nicotine | 1 | 1992 | 677 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2015 | 2509 | 0.020 |
Why?
|
Electroporation | 1 | 2008 | 254 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1854 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 426 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9599 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8426 | 0.020 |
Why?
|
Reaction Time | 1 | 2012 | 2075 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 553 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1988 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2500 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13276 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1668 | 0.020 |
Why?
|
Optic Nerve | 1 | 2008 | 567 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3364 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2022 | 4761 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15773 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2646 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2006 | 931 | 0.010 |
Why?
|
Oculomotor Muscles | 1 | 2008 | 407 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2006 | 785 | 0.010 |
Why?
|
Neoplasms | 2 | 2010 | 22032 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2006 | 835 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5790 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2006 | 427 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2796 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1055 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3526 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1262 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9304 | 0.010 |
Why?
|
Autoantibodies | 1 | 2011 | 2118 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1134 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 881 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9311 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3593 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2504 | 0.010 |
Why?
|
Cell Membrane | 1 | 2008 | 3680 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4603 | 0.010 |
Why?
|
Cell Communication | 1 | 2005 | 1651 | 0.010 |
Why?
|
Immunoblotting | 1 | 2001 | 1647 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2001 | 959 | 0.010 |
Why?
|
Spermatogenesis | 1 | 1998 | 257 | 0.010 |
Why?
|
Spinal Cord | 1 | 2005 | 1814 | 0.010 |
Why?
|
Eye | 1 | 2001 | 710 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4169 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 4711 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3796 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2008 | 3941 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1990 | 9160 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 2774 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10416 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12721 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2008 | 15637 | 0.000 |
Why?
|